Register
Formulation Development

Latest Headlines
Xcelience and IriSys business alliance agreement strengthens regional access to CMC/Regulatory expertise
More...
Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area
More...
Xcelience and Penn Pharma Form a Joint Venture to Provide API Into Capsule Services in Europe and Asia Pacific Markets
More...





Featured Publication
Recent Options for Phase 1 Formulation Development and ClinicalTrial Material Supply. By: Balaji V. Kadri - Featured in the August 2008 Issue of Pharmaceutical Technology



Case Studies

Case Study 5
Clinical Proof of Concept Study with an Accelerated Time Frame



A specialty pharmaceutical company needed help with a clinical protocol intended to determine the doses in a fixed-dose combination product. This project had very short timelines imposed by regulatory filing commitments as well as a lean budget.


The Xcelodose encapsulation machine was used to put the API directly into a hard gelatin capsules. This eliminated the need to formulate with excipients and greatly decreased the time needed to produce clinical supplies.


Capsules were manufactured at strengths down to 100 ug while meeting the dose uniformity specifications set for the clinical trial materials


The timeline and cost requirements were met by Xcelience.











Home | Services | Corporate | Publications | Equipment List | Resources | News | Career | Contact


Drug Development Services | Pharmaceutical Pre-Formulation Development | Pharmaceutical Formulation Development
Drug Development Analytical Method | Xcelodose Drug Manufacturing | Drug Delivery Expert Consulting | BOOKMARK US

Copyright © 2010 Xcelience All rights reserved.
Website Designed by GI & Hi-Tech - Tampa, FL